1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Metabolism and l-Methyl-4-Phenylpyridinium Uptake in Dissociated Cell Cultures from the Embryonic Mesencephalon
- 1 June 1988
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 50 (6), 1900-1907
- https://doi.org/10.1111/j.1471-4159.1988.tb02495.x
Abstract
1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP), a contaminant found in a synthetic illicit drug, can elicit in humans and monkeys a severe extrapyramidal syndrome similar to Parkinson's disease. It also induces alterations of the dopamine (DA) pathways in rodents. MPTP neurotoxicity requires its enzymatic transformation into 1‐methyl‐4‐phenylpyridinium (MPP+) by monoamine oxidase followed by its concentration into target cells, the DA neurons. Here, we show that mesencephalic glial cells from the mouse embryo can take up MPTP in vitro, transform it into MPP+, and release it into the culture medium. MPTP is not taken up by neurons from either the mesencephalon or the striatum in vitro (8 days in serum‐free conditions). However, mesencephalic neurons in culture revealed a high‐affinity uptake mechanism for the metabolite MPP+, similar to that for DA. The affinity (Km) for DA uptake is fivefold higher than that for MPP+ (0.2 and 1.1 μM, respectively), whereas the number of uptake sites for MPP+is double (Vmax= 25 and 55 pmol/mg of protein/min for DA and MPP+, respectively). Mazindol, a DA uptake inhibitor, blocks the uptake of DA and MPP+ equally well under these conditions. Moreover, by competition experiments, the two molecules appear to use the same carrier(s) to enter DA neurons. Small concentrations of MPP+ are also taken up by striatal neurons in vitro. The amount taken up represented + uptake in mesencephalic neurons. Depolarization induced by veratridine released comparable proportions of labeled DA and MPP+ from mesencephalic cultures. These data support the view that MPTP is transformed into MPP+ by astrocytes and concentrated in DA neurons by a relatively specific uptake system, similar to that for DA.Keywords
This publication has 32 references indexed in Scilit:
- Uptake, Release, and Subcellular Localization of l‐Methyl‐4‐Phenylpyridinium in Blood PlateletsJournal of Neurochemistry, 1987
- Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomesBiochemical and Biophysical Research Communications, 1985
- Positive control of target cerebellar cells on norepinephrine uptake in embryonic brainstem cultures in serum-free mediumDevelopmental Brain Research, 1984
- Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeysEuropean Journal of Pharmacology, 1984
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- Tracing the development of oligodendrocytes from precursor cells using monoclonal antibodies, fluorescence-activated cell sorting, and cell cultureDevelopmental Biology, 1983
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences, 1983
- Long-term development of mesencephalic dopaminergic neurons of mouse embryos in dissociated primary cultures: Morphological and histochemical characteristicsNeuroscience, 1982
- Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditionsNature, 1980
- Release of dopamine from dissociated mesencephalic dopaminergic neurons in primary cultures in absence or presence of striatal target cellsBrain Research, 1980